An inbred polymyopathic strain of Syrian hamsters (Mesocricetus auratus) has been under intensive study since its initial characterization by Homburger et al. (1962a) . It has been regarded with some justification as an experimentally accessible model for muscular dystrophies and for chronic congestive heart failure in general (Bajusz, 1969) . The disease appears to be genetically determined as an autosomal recessive trait (Homburger et al., 1962b) . Thus far, only striated muscles have been believed to be primarily affected in these animals, with secondary lesions developing in other organs as a result of defective performance of the heart and skeletal muscles. This does not necessarily imply that the actual genetic lesion is restricted in its expression to differentiated muscle cells, but simply that the most significant effects are experienced there as regards physiological functions. Detailed histopathological or biochemical studies of tissues other than striated muscles, at an early stage of the disease, have not been reported.
The elucidation of the primary genetic defect in these hamsters is important as the first step in a deVol. 132 tailed study of the sequence of events, in molecular terms, leading to the severe morphological and functional impairment. Preliminary electron-microscopic studies have suggested that heart-muscle cells are poorly developed at birth in affected animals , but no detailed morphological study is available.
We have studied in vitro the synthesis of proteins in heart-and skeletal-muscle preparations from both these hamsters and from control animals, in an attempt to detect the primary genetic abnormality and its biochemical sequelae. Cell-free protein synthesis by smooth muscle, liver and brain fractions has also been investigated for purposes of comparison.
Materials and Methods Animals
Syrian hamsters (strain BIO 14.6) were imported from the Bio-Research Institute, Boston, Mass., U.S.A. and maintained by random in-breeding in our 7 hamster colony, in parallel with control hamsters from the London School of Hygiene. They were given EPOL hamster pellets (Vereeniging Consolidated Mills, Cape Town, South Africa) ad libitum.
Scintillation chemicals
Fluoralloy obtained from Beckman Instruments, Cape Town, South Africa, was diluted with toluene (chromatography grade) to a 10% (v/v) solution, containing 0.6% 2,5-diphenyloxazole and 0.1 % 1,4-bis-(5-phenyloxazol-2-yl)benzene. 
Preparation ofsubcellular fractions
After decapitation of hamsters, the hearts and skeletal muscles (limbs and pectoral area) were removed and dissected free of connective tissue. Homogenates were prepared in medium A, containing (final concns.): 0.25M-sucrose, lOmM-MgCl2, 80mM-KCl and 50mM-Tris-HCI buffer, pH7.8. All procedures were carried out at 0-4°C.
(1) Polyribosomes. Polyribosomes from hearts, skeletal muscles and uteri were prepared by the method of Florini & Breuer (1966) (3) High-speed-supernatant fractions (5100). The postmitochondrial supernatant was centrifuged at 105000ga. for 120min as described above. Small quantities of the supernatant (l.Oml) were passed through columns (1 cm x 30cm; void volume 5.5 ml) of Sephadex G-25 (fine grade), previously equilibrated with medium A, and eluted with the same buffer before storage at very low temperatures as described above.
(4) Liver andbrainpolyribosomes andpH5fractions. These were prepared from control and myopathic hamsters by the methods ofHawtrey &Nourse (1966) , except that the final precipitates were dissolved in medium A.
Incorporation oflabelled amino acids into protein
Two procedures were used to measure the incorporation of labelled amino acids into proteins. Reproducibility and counting efficiency were the 1973 same. In the first, the reaction medium used for incorporation studies contained (final concns.) in 1. and washed with 20ml each of cold 5% (w/v) trichloroacetic acid, ethanol-diethyl ether (1:1, v/v) and ether. The filters were dried before being placed in counting vials with 5 ml ofscintillation fluid. Radioactivity was determined in a liquid-scintillation spectrometer (Packard Tri-Carb model 525). In the second procedure, the more convenient method of Mans & Novelli (1961) was used. The final reaction volume was 0.25ml with identical reaction concentrations as described above. Two Whatman 3MM filter papers (diam. 2.5cm) per incubation mixture were used (100l,/fflter). All tests were carried out in triplicate and results never differed by more than 5 %.
Incorporation of labelled phenylalanine into polypeptide, with poly(U) as template The reaction medium used contained in 0.20ml: 40mM-Tris-HCl buffer, pH7.8, l5OmM-KCl, 6mM-MgCl2, 0.2M-sucrose, 1.6mM-ATP, 0.6mM-GTP, 5.OmM-phosphoenolpyruvate, lO,ug of pyruvate kinase, lOmM-2-mercaptoethanol, pH5 enzyme (0.5mg of RNA), polyribosomes (1.Omg of RNA) and S100 fraction (0.5mg of protein). The reaction mixture was preincubated for 60min at 37°C to allow polyribosomal 'run-off' from most of the endogenous mRNA and to release free 80S monoribosomes. After the preincubation, [3H]phenylalanine (2.5,uCi) and 70,g of poly(U), suspended in 1.OMMgCl2, were added to give a total reaction volume of 0.25ml and a final Mg2+ concentration of 1Smim. Blanks to which poly(U) was not added were incubated in each case. Incubation was carried out for a further 30min at 37°C and terminated by absorption of the mixtures on Whatman 3MM filter papers, which were further processed as described above.
Assay ofgeneral ribonuclease activity in pH5 enzyme fractions
The method of Herrington & Hawtrey (1969) was used for the determination of nuclease activity in Vol. 132 pH 5 enzyme fractions. Yeast RNA (previously dialysed against four changes of lOOOvol. of water for 24 h to remove free nucleotides) was used as substrate. Tubes containing 1.Oml of pH5 enzyme (60mg of protein), 0.8ml of medium A and 0.2ml of RNA substrate (2mg) were incubated at 37°C. At selected times, 0.5ml samples were removed and placed in tubes kept on ice and containing 5.Oml of 0.5M-HC104. After 30min at 0°C, the RNA and protein were collected by centrifugation at 1400g for 10min. The supernatant was assayed for liberated nucleotides by measuring the increase in E260. Tubes containing no pH 5 enzyme were included for analysis at the same selected times during incubation, to correct for RNA breakdown occurring in the absence of added enzyme. Nuclease activity was expressed as increased E260/mg of pH5 enzyme protein.
Acid proteinase activity in pH5 enzyme preparations This activity was measured by the method of Barrett (1967) . The denatured bovine haemoglobin substrate was in great excess over the endogenous pH5 proteins in solution. Enzyme activity was expressed as increased E280/mg of pH 5 enzyme protein.
Determination of RNA andprotein
Protein in all preparations was determined by the method of Lowry et al. (1951) , with bovine serum albumin as standard. The concentrations of RNA in pH 5 enzyme fractions were determined by the orcinol method (Mejbaum, 1939) with hydrolysed yeast RNA as standard.
Results
Effectiveness in protein synthesis ofpH5 enzyme fractions from myopathic and control hamster striated muscles When washed membrane-free polyribosomes from myopathic and control heart muscle of identical RNA content, were recombined with pH5 enzyme preparations from both types of animals [RNA content also standardized (Table 1) ], the system from myopathic animals was less active than the control in polypeptide synthesis directed by endogenous mRNA (Table 2) . Diminished protein synthesis catalysed by polyribosomes from control hamster heart muscle was also obtained by the substitution of pH 5 enzyme from myopathic muscle for that prepared from controls. This defect was thus present irrespective of the source of polyribosomes. It could be demonstrated in embryonic hearts, as well as in those of animals aged 2 months and 6 months. The differences were smaller with decreasing age, however, but remained highly significant. In skeletal-muscle preparations, a similar defect in the pH5 enzyme fractions from myopathic animals was demonstrable (Table 2 ). In very young animals, more of this tissue was available, and it was therefore preferentially used in certain experiments as a model for protein synthesis in muscle tissues.
To determine whether these differences were influenced by the time-course of events, parallel incubations of both systems were carried out for selected periods (Fig. 1) .
After an initial rapid increase of incorporation in both systems, this decreased to zero after 40min. The rate of incorporation in the system from myopathic animals, however, was definitely slower and reached a lower plateau value, indicating that the observed impairment affected both the initial rate of incorporation and the extent thereof. The negligible incorporation after 40 min may be ascribed to 'runoff' of ribosomes from mRNA molecules, in the absence of further reinitiation.
To ascertain how variations in the concentrations of polyribosomes and pH 5 enzymes might affect the incorporation of labelled amino acids into polypeptides, the polyribosome concentrations in systems from both myopathic and control animals were kept constant and the concentrations of pH 5 enzyme varied (Fig. 2a) ; Fig. 2(b) shows the results when the pH 5 enzyme concentration was kept constant and incubated with increasing amounts of polyribosomes. Increased concentrations of polyribosomes or pH5 enzyme could not eliminate the defect in myopathic animals, indicating that the latter was not simply quantitative but also qualitative in nature. Preincubation at 37°C of the pH5 enzyme fractions from both myopathic and control skeletal muscles resulted in decreased amino acid incorporation into protein by polyribosomes from both control and myopathic muscles (Table 3) ; the effect was greater in the defective fraction.
To determine whether this general pH 5 enzyme defect could also be expressed in a much more limited 1973 Age of animals Embryonic 2 months 6 months and well-defined system, poly(U)-directed polymerization of [14C]phenylalanine was studied. Here, initiation of peptide-bond formation could be assumed to be non-enzymic at the high Mg2+ concentration used (15mM) (Stanley et al., 1966) and only one tRNA (for phenylalanine) would be required. To study the activity of polyribosomes and pH 5 enzyme fractions from control and myopathic animals, with identical unrelated combination partners, polyribosomes and pH 5 enzymes were prepared from rat liver and combined with the separate fractions from both types of hamsters in all possible combinations.
The pH5 enzymes from both heart and skeletal Time of incubation (min) Fig. 3 . Nuclease activity on yeast RNA in pH5 enzymes from hamster skeletal muscles pH5 enzymes from control (a) and myopathic (o) animals were tested by using procedures described in the Materials and Methods section. muscles of myopathic animals were less active than their control partners in poly(U)-directed polyphenylalanine synthesis, when both were combined with the same liver polyribosomes (Table 4) . However, when the two types of muscle polyribosomes were incubated with the same pH 5 enzyme from rat livers, the polyribosomes from myopathic animals were more active than those from controls. Thus, the pH 5 enzyme defect observed also affects poly(U)-directed phenylalanine incorporation at high Mg2+ concentrations, where initiation of polypeptide synthesis by the initiation-codon-specific fMet-tRNA mechanism is not required. The initiation factors for protein synthesis are believed to be largely bound to polyribosomes (Heywood, 1970) , which particles appear to be unaffected by the existence of myopathy. At high Mg2+ concentrations with poly(U) as messenger, no release of chains takes place (Gilbert, 1963) .
Ribonuclease and proteinase activity in pH5 enzyme fractions An examination of general nuclease and acid proteinase activities in the pH 5 enzyme preparations was carried out to determine whether the observed defect in pH 5 enzyme from myopathic muscle might be due to hydrolysis of endogenous tRNA or mRNA by ribonuclease, or to degradation of the newly synthesized polypeptides by proteinases. Although the endogenous nuclease activities were a little greater in the pH 5 enzymes from myopathic animals than in those from controls (Fig. 3) , these differences were unlikely to account for the inhibition (by nearly 30 %) of amino acid incorporation into proteins seen in the reconstituted cell-free system. There was no difference between the acid proteinase activity in the two types of pH 5 enzymes; this was very low in either case (Fig. 4) .
Since bentonite is an effective absorbent of ribonuclease (Littauer & Sela, 1962) , pH 5 enzymes from myopathic and control animals were prepared in the presence of a very high concentration (5.0mg/ml) of bentonite (purified by the method of Nisman, 1968) , to eliminate the ribonuclease effect.
From the results (Table 5) it is evident that bentonite absorption of ribonuclease permitted a higher rate of amino acid incorporation by pH 5 enzymes from control and myopathic skeletal muscles, but a 20% difference between the two extracts was still found. It is thus improbable that the impairment in protein biosynthesis as catalysed by the pH 5 enzyme from myopathic animals, was due to contamination by endogenous endonucleases, but more likely that a general pre-existing defect in the enzyme fractions was responsible.
Performance of pH5 enzymes from hamster brains, livers and uteri in cell-free protein biosynthesis It was decided to ascertain whether the pH 5 enzyme defect was restricted to striated-muscle preparations, taking into account the prominence in these affected hamsters of heart failure and muscular dystrophy. Polyribosomes and pH 5 enzymes were isolated from control and myopathic hamster brains, livers and uteri and were incubated in different combinations to measure cell-free protein biosynthesis.
When polyribosomes and pH 5 enzymes from myo- Time of incubation (min) Fig. 4 . Acid proteinase activity on denatured bovine haemoglobin in pH5 enzymes from myopathic (0) andcontrol (a) hamster skeletal muscles
Procedures used are described in the Materials and Methods section. that the impaired performance of soluble fractions of myopathic origin in polypeptide formation was not an artifact produced during our preparative procedures, but probably existed in the intact tissue before homogenization.
The pH 5 enzyme defect was also present in smooth muscles. When pH 5 enzyme from uteri of myopathic hamsters was combined with polyribosomes from uteri of control or myopathic animals, a similar defect was found (Table 6 ).
Discussion
It is clear that the number of causes of genetically determined muscular dysfunction may be very large because of the complicated interrelationship between energy production and the contractile mechanism in the general physiology of muscle cells. For example, increased myocellular 'acid' cathepsin activity has been described in chicken muscular dystrophy, where it is believed to be responsible for the loss of muscle protein (lodice etal., 1966) . Pennington (1963) has made similar observations in dystrophic skeletal muscle of mice, including an increased activity of 'alkaline' proteinase. Studies of creatine kinase in mouse muscular dystrophy have revealed the presence of an abnormal enzyme molecule lacking one of the two essential thiol groups of the normal dimeric enzyme (Hooton & Watts, 1966) . Defects in sarcosomal oxidative phosphorylation have been detected at late stages of polymyopathy in the same Syrian hamster strain we have used for our studies (Lochner & Brink, 1967; Lochner et al., 1968; Schwartz et al., 1968 ). An abnormal foetal-type metmyoglobin has been detected in the muscles ofpatients with progressive muscular dystrophy (Whorton et al., 1961) .
In all these instances the primary defects are likely not to be the rather specific biochemical abnormalities reported, but some unknown lesions which lead to the different histopathological and functional syndromes and, inter alia, to detectable secondary changes. Only in 'acid' maltase deficiency (glycogenosis type II of Hers, 1963) has the genetic defect causing a polymyopathy been localized to an inactive lysosomal enzyme, and even here the full picture of the disease process cannot be rationally explained on the basis of the single abnormality postulated (Engel, 1970) . The tremendous difficulty of distinguishing between primary and secondary phenomena needs hardly to be emphasized. On the other hand, elucidation of the true primary lesion, and a detailed description of the evolving secondary changes, is likely to be extremely valuable for our understanding of muscle physiology and pathology.
We have detected an abnormality in the 'soluble' cytoplasmic machinery involved in reconstituted protein-synthesizing systems from the polymyopathic Syrian hamster, not only in the heart and skeletal muscles, but also in uterine smooth muscle and in the liver and brain. The defect in the muscle system is both qualitative and quantitative in nature, implying that there is a shortage of some essential soluble component in the pH 5 enzyme fractions, which is accompanied by the presence ofan altered substituent which prevents the attainment of extents of polypeptide synthesis in vitro seen in control extracts from unaffected animals.
The use of fractions standardized with respect to RNA and protein concentrations obviates the need to consider these factors as causes of the impaired performance of soluble components from myopathic animals. We have in fact found that the yield, per heart, ofpolyribosomes and pH 5 enzymes is increased in parallel in older myopathic animals compared with controls. Watts & Reid (1969) have concluded that the cell-free protein-synthesizing mechanism in myodystrophic Bar Harbor mice is similar to that of normal mice when the activity is expressed in such a way as to allow for the decrease in muscle volume occurring in the abnormal muscle mass.
It is difficult to define the cellular origin of isolated enzyme and polyribosome fractions when there may be significant variations in the distribution of myocytes, phagocytes and connective-tissue cells in heart muscle at different phases of development, both in the normal hamsters and in the polymyopathic animals where there is clear evidence for such changes as the disease progresses (Caulfield, 1966) . This consideration would be more significant had our results indicated an increased activity in protein synthesis rather than the observed decrease, since the non-myocytic cells would be expected to become metabolically more active in diseased muscle. Grove et al. (1969) have demonstrated that increases in DNA synthesis observed in hypertrophying heart muscle are caused exclusively by fibroblastic proliferation and not by myocytic events, whether nuclear or mitochondrial.
The existence of a generalized tissue defect, demonstrable even at the embryonic developmental stage, may thus be closely related to the primary genetic defect causing the syndrome of polymyopathy in the BIO 14.6 strain of hamsters.
